Summary of Product Characteristics & Investigator's Brochure

For copies of the latest and previous versions of documents distributed for this trial, please contact the MyeChild-01 Trial Office at myechild01@trials.bham.ac.uk.

  • Busilvex (Busulfan) 6mg/ml [.pdf]
  • Cyclophosphamide 500mg [.pdf]
  • Cytarabine 20mg/ml [.pdf]
  • Cytarabine 100mg/ml [.pdf]
  • Fludarabine Phosphate 25mg/ml [.pdf]
  • Fludarabine Phosphate 50mg [.pdf]
  • Liposomal Daunorubicin (DaunoXome) 2mg/ml [.pdf]
  • Mitoxantrone (Mitozantrone) 2mg/ml [.pdf]
  •  For the Gemtuzumab Ozogamicin Investigator's Brochure, please email the MyeChild 01 Trials Office.